Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone905-842-5150
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Concordia International (NASDAQ:CXRX) Frequently Asked Questions
What is Concordia International's stock symbol?
Concordia International trades on the NASDAQ under the ticker symbol "CXRX."
How were Concordia International's earnings last quarter?
Concordia International Corp (NASDAQ:CXRX) announced its earnings results on Friday, August, 12th. The company reported $1.38 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.38. The firm earned $231.70 million during the quarter, compared to the consensus estimate of $229.76 million. Concordia International's quarterly revenue was up 208.1% on a year-over-year basis. View Concordia International's Earnings History.
Has Concordia International been receiving favorable news coverage?
Headlines about CXRX stock have been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Concordia International earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 9.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Concordia International.
Who are some of Concordia International's key competitors?
Some companies that are related to Concordia International include Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), ARMO Biosciences (ARMO), Bohai Pharmaceuticals Group (BOPH), Egalet (EGLT), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), Evotec (EVTCY), FutureWorld (FWDG), GlobeImmune (GBIM), Impax Laboratories (IPXL) and Merck KGaA (MKGAF).
What other stocks do shareholders of Concordia International own?
Who are Concordia International's key executives?
Concordia International's management team includes the folowing people:
- Mr. Allan Oberman, CEO & Director (Age 60)
- Mr. Francesco Tallarico, Chief Legal Officer & Sec. (Age 35)
- Mr. Adrian A. de Saldanha, Exec. (Age 57)
- Mr. Adeel Ahmad, Chief Financial Officer of Concordia International Segment (Age 44)
- H.R.H. David J. Price, Chief Financial Officer (Age 55)
How do I buy shares of Concordia International?
Shares of CXRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Concordia International's stock price today?
One share of CXRX stock can currently be purchased for approximately $0.19.
What is Concordia International's official website?
How can I contact Concordia International?
Concordia International's mailing address is 277 LAKESHORE RD. E. SUITE 302, OAKVILLE A6, L6J1H9. The company can be reached via phone at 905-842-5150 or via email at [email protected]
MarketBeat Community Rating for Concordia International (NASDAQ CXRX)
MarketBeat's community ratings are surveys of what our community members think about Concordia International and other stocks. Vote "Outperform" if you believe CXRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CXRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
